Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Jordi Rodon Ahnert

Provisional: name at one institution (moderate confidence)As of 10 November 2026

Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.

Their work

Papers
0
Trials
3 (principal investigator on 2)
Grants
0
Collaborators
0
Papers, trials and grants by year

2018: 1 trial · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 trial · 2025: none · 2026: 1 trial

Trials 3

  1. Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss Principal investigator NCT07382544↗
  2. A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic Cancer Principal investigator NCT06199466↗
  3. Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene Study chair NCT03602079↗

Closest collaborators

No collaborators recorded.

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.